Amyotrophic lateral sclerosis is a neurodegenerative disease characterised by selective degeneration of motor neurons. This ...

New research from King's College London has revealed a connection between ancient viral DNA embedded in the human genome and ...

The study identified which specific HERVs are important in increasing susceptibility for neurodegenerative diseases.

A toxic version of a certain protein may affect brain, spinal cord and skeletal muscle tissues differently, leading to the ...

The DJC first reported in 2022 on architecture firm The Miller Hull Partnership's work in Spokane with Matt's Place ...

A promising ALS drug may help combat glioblastoma by targeting the cancerous stem cells that fuel tumor growth.

Oditrasertib, which blocks the inflammatory RIPK1 protein, earlier this year also failed a Phase II trial in amyotrophic ...

Sanofi has stopped a phase 2 trial of Denali Therapeutics-partnered oditras | Sanofi has stopped a phase 2 trial of the ...

Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection 25 mg” ...

Hall, founder of Beacon of Hope for ALS, aims to lift people up and help them after their diagnosis. Amyotrophic lateral ...